Abilia, a subsidiary of MedCap, has reached agreement on the acquisition of LivAssured B.V., a Dutch medtech company best known for its medical device Nightwatch, an innovative solution for detecting epileptic seizures. Through this acquisition, Abilia strengthens its portfolio within assistive technology and deepens its mission to deliver reliable, research-based solutions for people in need of medical support. The transaction includes the acquisition of 100% of the shares in LivAssured B.V.